🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to describe asenapine prescribing patterns in the Un...
Status
Completed
Location
Multiple Locations
Start Date
2013-04-01
Trial ID
NCT01498770
This study will test the effectiveness of two different treatments for chil...
Status
Completed
Location
University of Maryland
Start Date
2009-01
Trial ID
NCT00806234
This prospective, multicenter, non-comparative, open-label trial design aim...
Status
Recruiting
Location
Shanghai Sixth People's Hospital
Start Date
2026-03-10
Trial ID
NCT07482891
Treatments Being Tested
This is a multicenter, randomized, controlled, double-blind, phase III stud...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2020-10-01
Trial ID
NCT04536558
The purpose of this study is to examine whether olanzapine, compared to ris...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2003-04
Trial ID
NCT00485498
Treatments Being Tested
This randomized phase III trial studies how well olanzapine with or without...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2018-11-20
Trial ID
NCT03578081
This is a single-site, open-label, randomized pilot feasibility study condu...
Status
Not Yet Recruiting
Location
Ottawa Hospital Cancer Centre
Start Date
2026-08
Trial ID
NCT07662200
Treatments Being Tested
The aim of this study is observation, in an Italian real-world setting, of ...
Status
Completed
Location
Ospedali Riuniti SOD di Clinica Psichiatrica
Start Date
2020-07-13
Trial ID
NCT04312503
Treatments Being Tested
Evaluate the efficacy of nizatidine in reducing/limiting weight gain in pat...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2003-02
Trial ID
NCT00486005
Treatments Being Tested
The purpose of this study is to explore the safety, tolerability, and poten...
Status
Completed
Location
Multiple Locations
Start Date
2011-05
Trial ID
NCT01323205
Treatments Being Tested